|
|
Pediatric RSV Prophylaxis: An Evolving Landscape for Prevention " A Wheel of Knowledge Challenge!
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age in the United States. Although certain infants and young children are at higher risk for severe illness due to premature birth or comorbid conditions, the majority of pediatric RSV hospitalizations occur in healthy infants. Emerging passive immunization options, which include nirsevimab and a maternal RSV vaccine, provide important new tools that offer RSV protection... |
|
|
9th Annual Internal Medicine in Primary Care Conference
Prepare to embark on an extraordinary voyage of discovery and rejuvenation aboard the Celebrity Edge, where the 9th Annual Internal Medicine in Primary Care Conference awaits amidst the awe-inspiring landscapes of Alaska. From July 25 to August 1, 2025, immerse yourself in the natural splendor of the Inside Passage as you sail through pristine fjords, past towering glaciers, and alongside majestic wildlife. This unique cruise offers a perfect blend of educational enrichment and leisurely explo... |
|
|
Optimizing Early Nutrition for Long-Term Benefits
Sharon Donovan, PhD, RD, and Michael Georgieff, MD, review what is currently known about the influence of nutrition during the first 1,000 days of growth and development. Human milk"the model for optimal nutrition"is discussed, including its nutritive and nonnutritive components, how it functions as a dynamic biological system, and the latest breastfeeding guidelines. The implications of suboptimal early nutrition are addressed, along with the role of pediatric clinicians in providin... |
|
|
DETECT" Advances in the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician
Target Audience
This activity is designed to meet the educational needs of Pediatric Endocrinologists, Adult Endocrinologists, Pediatricians, Primary Care Providers (PCPs), and Endocrine Nurses.
Program Overview
This educational program focuses on the early screening, detection, and advances in the treatment of early-stage type 1 diabetes (T1D). Through this enduring Grand Rounds session, clinicians will be able to review the importance and benefits of early screening, how to screen &... |
|
|
A Primer on IgE-Mediated Food Allergies, With Drs. Kelly Cleary and Barbara Yawn
In this CE podcast, developed in collaboration with Food Allergy Research & Education (FARE), experts review the pathophysiological underpinnings of IgE-mediated food allergies and discuss the importance of shared decision-making and interdisciplinary approaches to optimize patient care. |
|
|
Advances in the Management of IgE-Mediated Food Allergies, With Drs. Kelly Cleary and Robert Wood
In this podcast, expert clinicians will discuss the efficacy and safety of traditional and emerging treatments as well as evidence-based guidance for managing patients with immunoglobulin E (IgE)-mediated food allergies. |
|
|
Beyond Avoidance: IgE-Mediated Food Allergies " Therapeutic Innovations to the Rescue
In the United States, food-induced allergic reactions are the leading cause of anaphylaxis in hospital emergency departments. Among these, immunoglobulin E (IgE)-mediated food allergies are the most common, and they pose significant risks, including cardiac arrest and respiratory failure. Traditionally, treatment options for IgE-mediated food allergies have been primarily limited to food avoidance and anaphylaxis prevention. However, recent years have brought the FDA approval of the first oral... |
|
|
Managing Obesity in Adolescent Patients Your Top 10 Questions Answered
The rate of obesity in children and adolescents is increasing, posing significant physical and mental health challenges through childhood and adolescence and into adulthood. Recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been approved for use in patients as young as 12 years, and it is critical that clinicians initiate both lifestyle management and pharmacologic therapies as early as possible. Dr. Fatima Stanford discusses 10 common questions asked about managing obesity ... |
|
|
Are You Up to Speed? Test Your Knowledge on Pneumococcal Vaccination in Adults
Despite widespread availability of pneumococcal vaccines designed to reduce the risks for infection and invasive pneumococcal disease, coverage remains suboptimal among older adults and those with underlying medical conditions and risk factors. The development of pneumococcal conjugate vaccines offers new opportunities for improved protection against pneumococcal disease, but are you current with the latest evidence and guideline recommendations? If you're a puzzle enthusiast, dive into t... |
|
|
Musculoskeletal Ultrasound: Introduction with Interventional Cadaver Lab - Live Course
The Musculoskeletal Ultrasound: Introduction with Interventional Cadaver Lab Training Course provides participants a comprehensive introduction to musculoskeletal ultrasound. This course is taught by leading musculoskeletal ultrasound experts and incorporates comprehensive lectures covering anatomy, pathology, and ultrasound-guided injection/aspiration techniques. Live scanning demonstrations are included for each upper and lower extremity joint.
Extensive hands-on scanning sessions feature... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing that utilizes cancer biomarkers in the blood to screen for multiple cancers simultaneously (ACS, 2024). Currently, numerous clinical trials are investiga... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States (ACS, 2024; Pinsky & Berg, 2012; USPSTF, 2024). Multicancer early detection (MCED) is a novel form of blood-based ca... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Advances In the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician - Part 3
Target Audience
This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers, and Endocrine Nurses.
Program Overview
During this program, experts will present overviews of the importance of early screening and staging for type 1 diabetes (T1D), strategies and practical pearls for screening and follow-up, how to intervene early with disease-modifying therapies to delay progression to clinical T1D, as well as ongoing ... |
|
|
Mastering Suboptimal Treatment Response in nAMD
In this Master Class case, Dr. David Eichenbaum discusses the management of a 69-year-old White man with neovascular age-related macular degeneration who receives a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy. |
|
|
Mastering Suboptimal Treatment Response in DME
In this Master Class case, Dr. W. Lloyd Clark discusses the management of a 75-year-old Black woman with diabetic macular edema who has a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy. |
|
|
Recognizing and Confirming Potential ATTR in Your Patients
Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.
Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part ... |
|
|
Navigating the Evolving Standards of Newly Diagnosed Multiple Myeloma Treatment: Exploring the Evidence on New Combination Strategies
ACTIVITY DESCRIPTION
The goal of treatment for newly diagnosed multiple myeloma (NDMM) patients is achieving the deepest possible remission, which typically involves aiming for minimal residual disease negativity. Frontline therapy for NDMM is evolving to include novel induction regimens with anti-CD38 antibodies, which have been shown to yield improved depth of response after induction. These new frontline treatments vary in induction regimen composition and use of transplant, consolidation,... |
|
|
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
Multimodal imaging is key for the early detection and monitoring of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Optical coherence tomography has recently been recommended by an international consensus to be the primary imaging method for the detection of atrophy in eyes. Once diagnosed, timely therapeutic intervention should be initiated with recently FDA-approved therapies that target components of the complement cascade. When optimally integrated into persona... |
|
|
Podcast: Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
With the complex and rapidly evolving treatment landscape of multiple myeloma, it is vital that clinicians not only understand factors for informing selection of current and emerging combination and sequential therapeutic strategies, but also employ interdisciplinary strategies for reducing disparities in relapsed/refractory multiple myeloma care. The development of novel therapeutic options has significantly improved treatment outcomes for patients with relapsed/refractor... |
|
|
Defining the therapeutic algorithm in patients with HR positive breast cancer - United States
Target Audience
The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer
Learning Objectives
Upon completion of this activity, participants should be better able to:
Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall
Apply the most recent evid... |
|
|
Antibody Drug Conjugates (ADC) - United States
Target Audience
The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall
Apply the most recent evi... |
|
|
Bridging the Health Gaps in Hereditary Angioedema: Demystifying Disparities, Enhancing Quality of Life, and Implementing Effective Prophylactic Solutions
Hereditary angioedema (HAE) is a rare, life-threatening disorder characterized by recurrent, unpredictable episodes of bradykinin-induced swelling. In this presentation, Dr. Marc Reidl, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center, reviews multiple underrecognized factors that contribute to health disparities among patients with HAE, including delays in diagnosis and multifaceted differences among racial and ethnic groups, socioeconomic status levels, ... |
|
|
Best of ACTHIV® 2024: Sexually Transmitted Infections: Epidemiology and Missed Opportunities
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on current trends of common nationally notifiable STIs, potential challenges to diagnosing and treating chlamydia, gonorrhea, and syphilis, and how teams can apply knowledge of screening and treatment of syphilis in pregnant persons to prevent congenital syphilis.
Learning Objectives
Describe the ... |
|
|
Treating SCLC in the Relapsed/Refractory Setting: Giving Patients a Voice About Second-Line Therapy
SCLC is aggressive in nature with a high recurrence rate following initial treatment and a propensity to become resistant to conventional therapies. Early detection is critical, but many patients are diagnosed at an advanced stage where prognosis is poor. Progress in the second-line setting offers new hope for improving patient outcomes, but the rapid pace at which these advances are occurring present challenges for effectively integrating novel therapies into patient care. In fact, research s... |
|
|
Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss. However, diagnosis can be challenging. Traditional treatments for TED, such as steroids, radiotherapy, and surgery, all relieve symptoms but do not alter the course of dise... |
|
|
Overcoming the Hurdles: Advances in the Management of Hemophilia
In this fast-moving, 1-hour accredited activity, Craig Kessler, MD, and Guy Young, MD, share their thoughts and experience with clotting factor concentrates, recombinant factor, factor VIII mimetics, rebalancing agents, and gene therapies. The safety and efficacy of late-phase investigational products are also discussed as these agents have the potential to address unmet needs and further transform patient care. |
|
|
Cushing’s Syndrome Treatment Research Highlights: ENDO 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in endorcrinology, radiology, neurosurgery, and general practice. Other members of the care team may also participate.
Program Overview
This 30-minute CME program highlights the latest clinical research about Cushing’s syndrome and Cushing’ disease.
Learning Objectives
After participating in the activity, learners should be better able to:
Describe the latest research being ... |
|
|
Extending Dosing Intervals in Retinal Disease: Patient Perspectives and Clinical Insights to Guide Your Practice
Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are increasingly prevalent retinal diseases that pose significant challenges in ophthalmic care. While anti-vascular endothelial growth factor (VEGF) therapies have greatly improved visual outcomes for patients with these conditions, real-world data indicate that many patients receive suboptimal treatment and monitoring, resulting in poorer visual outcomes. Newer therapeutic options have been developed to exte... |
|
|
Patient‐Centered GA Care: A Synergistic Approach to Optimize Management
The recent FDA approval of 2 novel therapies for the management of patients with geographic atrophy (GA) secondary to age-related macular degeneration has further reenforced the necessity for early GA diagnosis to limit progression. Advances in imaging technologies now provide tools for better detection and characterization of GA, along with biomarkers to monitor progression over time. Optometrists, as front-line eye healthcare providers, play a critical role in the timely diagnosis, managemen... |
|
|
The Pharmacist’s Role in Individualizing Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, immune-mediated neurologic disorder that can lead to severe disability if left untreated. Early and accurate diagnosis for CIDP is challenging and usually delayed, but early initiation and maintenance of immunoglobulin-based treatment is crucial. Due to the heterogenous nature of the disease, treatment strategies need to be individualized, and pharmacists play an integral role through ongoing patient communications/education, ... |
|
|
Opportunities with Novel Therapies to Treat the Entire Spectrum of Schizophrenia Symptoms
Available antipsychotic therapies for schizophrenia are effective in treating positive symptoms of schizophrenia yet significant unmet needs remain, including therapies that (1) are more effective in reducing negative and cognitive symptoms of schizophrenia; 2) have improved tolerability and adherence rates; and (3) that are effective in treating refractory schizophrenia. Fortunately, the schizophrenia treatment landscape is poised to change dramatically, offering new opportunities for patient... |
|
|
Case Studies in ART and Retention in Care
Webinar Highlights:
It is estimated that approximately 54% of patients with HIV in the United States were retained in care in 2022. By remaining engaged in care, patients are more likely to be adherent to antiretroviral therapy resulting in viral suppression, improved patient outcomes and prevent the spread of HIV.
Through a series of cases, our interprofessional faculty educators will discuss potential barriers to retention in care commonly encountered by the healthcare team and provide ... |
|
|
Prevention of Medical Errors in Nursing Practice
STATEMENT OF NEED
Medical errors are among the most common health-threatening mistakes that affect patient care, accounting for as many as 250,000 deaths per year in the United States (Makary & Daniel, 2016). Medical errors are considered a global problem; they affect as many as 20% of patients in primary and outpatient care and complicate a patient’s primary condition for which they needed medical attention (WHO, 2019). These errors can lead to adverse outcomes, such as increased mor... |
|
|
THE MICRONUTRIENTS: Vitamin A & Carotenoids
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone pass... |
|
|
THE MICRONUTRIENTS: Survey of 13 Vitamins, Deficiencies, Supplements, and Interactions (Home Study Bundle)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
The Retina Radar With Dr. Arshad Khanani on DR, GA, New Mechanisms, and Noninvasive Treatments
Retinal diseases are a leading cause of global vision impairment, driven by an increasing prevalence and the need for more effective treatment. Although clinical trials have shown promising results for various therapies, real-world application often yields less impressive outcomes due to factors like under-treatment and patient non-adherence. New and emerging therapies, particularly for conditions like diabetic macular edema (DME), diabetic retinopathy, and geographic atrophy (GA) secondary to... |
|
|
Cleveland Clinic Hospital Medicine
Cleveland Clinic Hospital Medicine features a comprehensive review of the most common and relevant conditions seen in the inpatient setting. A globally renowned faculty addresses the application of new evidence, interprets current guidelines and provides management strategies which can improve the quality of medical care. All physicians, nurses and physician assistants treating hospitalized patients will benefit from this thoughtful assessment of best practices in this critical area of medici... |
|
|
Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC.
Target Audience
The primary target audience for this activity are Academic and community-based physicians and team members, including hematologists, hematologic oncologists, medical oncologists, oncology nurses, NPs, PAs, and hematology-oncology pharmacists.
Statement of Need/Program Overview
Bispecific antibodies are relatively new agents in the treatment of multiple myeloma (MM). Because of this, many oncology clinicians are unfamiliar with their mechanism of action and the adverse even... |
|
|
Case Studies in Cardiovascular Disease Prevention and People with HIV
By participating in this webinar, you will have the opportunity to enhance patient care by gaining a deeper understanding of the unique cardiovascular risks faced by people with HIV. With this knowledge, you’ll be better equipped to work with your care team to tailor preventive strategies, leading to improved patient outcomes and more comprehensive care. Additionally, the webinar will help you stay current with best practices in the ever-evolving field of HIV care. By learning about the late... |
|
|
New Guidelines, Emerging Treatments, and Unexpected Patients: Understanding the Challenges of PAH
Target Audience
This activity is designed for nurse practitioners, nurses, and physician assistants who manage patients with or at risk for PAH.
Program Overview
It is a deadly disease and there’s still no cure, but with treatment, survival for patients with pulmonary arterial hypertension (PAH) can be significantly extended. Although rare, nurse practitioners are likely to encounter this cardiopulmonary disorder throughout their careers, and need to be familiar with the multiple dru... |
|
|
International Conference on Advancements in Surgery and Anaesthesia
Scientex Conferences is delighted to invite participants worldwide to the International Conference on Advancements in Surgery and Anesthesia, scheduled for November 07-08, 2025, in Dubai, UAE featuring global experts, researchers, and professionals to explore the latest innovations in surgery and anesthesia. The conference revolves around the theme "Innovating the Future of Surgery and Anaesthesia"
This premier event will bring together surgeons, anesthesiologists, researchers, an... |
|
|
Pediatric RSV Prevention " Unlocking New Insights
Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in infants and young children, particularly those under 1 year of age in the United States. While infants born prematurely or with underlying health conditions are at a higher risk for severe RSV illness, the majority of pediatric RSV hospitalizations occur in otherwise healthy infants. Recent advancements in passive immunization, including long-acting monoclonal antibodies and maternal RSV vaccines, introduce ... |
|
|
GA and Advances in Imaging and Surgery: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 2 of this 2-part educational activity, updates in geographic atrophy will be discussed, along with advances... |
|
|
nAMD, Diabetic Eye Disease, and RVO: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 1 of this 2-part educational activity, updates in state-of-the-art management strategies for neovascular ag... |
|
|
THE MICRONUTRIENTS: Thiamin (B1)
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|
|
THE MICRONUTRIENTS: Vitamin E
Pharmacists are often sought after for guidance on choosing and using nutritional supplements. However, many current pharmacists did not receive comprehensive education on vitamins and minerals during their academic training. Even those who did may not be up to date on recent research that has broadened our knowledge of how deficiencies and excesses of certain micronutrients can impact health, as well as how these nutrients may interact negatively with specific medications.
For anyone passi... |
|